Harris Survey Shows Public Opposes Saccharin Ban
A Harris poll of 1,625 adults finds strong public opposition to a total saccharin ban by the FDA, with many favoring labeling and limited sale. Despite FDA relaxations, confidence in federal regulation remains weak and lawmakers may push unrestricted use. The public backs labeled risks and sees potential for new sweeteners as a solution.
MENTIONED IN THIS ARTICLE
Food and Drug Administration
FDA
Man
Harris
Congress
Blacks in surgery get unequal care study finds
A Johns Hopkins led study in the New England Journal of Medicine shows Black patients in gallbladder and hernia surgeries were more often treated by resident, less experienced surgeons than white patients, even with insurance. Across 1952 to 1972 and in October 1975 emergencies, Blacks faced higher resident care rates.
MENTIONED IN THIS ARTICLE
Boston
Lawrence D. Egbert
Johns Hopkins University
New England Journal of Medicine
Egbert
Senate panel votes to delay saccharin ban
The Senate Human Resources Committee voted 11 to 4 to suspend a ban on saccharin for 18 months, despite cancer concerns raised by studies in lab animals. The panel approved labeling requirements and directed studies on detection methods and saccharin impurities, sending the bill to the Senate floor amid expected prolonged debate.
MENTIONED IN THIS ARTICLE
Senate
Washington
Senate Human Resources Committee
Food and Drug Administration
Senat
Gaylord Nelson
D-Wis
Nelson
House
Congress
US expands warning of X ray cancer link
The National Cancer Institute urges over a million Americans who had head and neck X ray treatments for conditions such as ringworm or acne to immediate and regular thyroid checks every two years. Diagnostic dental or fracture X rays are not a concern.
MENTIONED IN THIS ARTICLE
Washington
National Cancer Institute
Also Mentioned on This Page
Harris Survey
By Louis Harris
Secretary of Health, Education and Welfare
U.S
Long Beach
Teresa
Fisst Federal Savines
Long Reach
Ocean Ave
AY Oke
Ximeno Ave
Pacific Ave
Wed
Thurs
Posi